75. クッシング病 [臨床試験数:191,薬物数:172(DrugBank:48),標的遺伝子数:61,標的パスウェイ数:121

Searched query = "Cushing disease", "Cushing"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN0000029252009/12/0128/12/2009Efficacy of Eplerenone monotherapy and Valsartan monotherapy on patients of Subclinical Cushing's syndrome with hypertension and non-functioning adrenocortical adenoma with hypertension.Efficacy of Eplerenone monotherapy and Valsartan monotherapy on patients of Subclinical Cushing's syndrome with hypertension and non-functioning adrenocortical adenoma with hypertension. - A pilot study to compare efficacy of Eplerenone monotherapy with Valsartan monotherapy. Subclinical Cushing's syndrome with hypertension and non-functioning adrenocortical adenoma with hypertension.50mg of Eplerenone monotherapy once daily for 6 weeks on subclinical Cushing's syndrome
80mg of Valsartan monotherapy once daily for 6 weeks on subclinical Cushing's syndrome
50mg of Eplerenone monotherapy once daily for 6 weeks on non-functioning adrenocortical adenoma
80mg of Valsartan monotherapy once daily for 6 weeks on non-functioning adrenocortical adenoma
Hiroshima University HospitalDepartment of Endocrinology and Diabetes mellitusNULLComplete: follow-up complete20years-oldNot applicableMale and Female80Not selectedJapan